Security
ASTH · Astrana Health, Inc.
ASTHNASDAQCommon stockCurrentCIK 1083446Updated Sep 26, 2026
Name history
Apollo Medical Holdings, Inc. · through Feb 13, 2024SICLONE INDUSTRIES INC · through Jul 15, 2008
ASTH price & chart
Loading TradingView…
NASDAQ:ASTH on TradingView ↗About the company
Astrana Health is a physician-centric, AI-powered healthcare company committed to delivering high-quality, patient-centered care. Built from the physician's perspective, Astrana combines its scalable care delivery infrastructure, proprietary technology platform, and aligned provider networks to enable proactive, preventive care at scale - improving patient outcomes, enhancing patient experiences, supporting provider well-being, and driving greater value across the healthcare system.
In the news
Lowey Dannenberg, P.C. is Investigating Astrana Health, Inc. (NASDAQ: ASTH) for Potential Violations of the Federal Securities Laws ↗
Astrana Health, Inc. Reports Second Quarter 2026 Results ↗
Astrana Health, Inc. Reports Fourth Quarter and Year End 2025 Results ↗
Recent filings
Regulation FD Disclosure
Items 7.01, 9.01
Material Cybersecurity Incidents
Items 1.05
Regulation FD Disclosure
Items 7.01, 9.01
4 filing
4 filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 2,218,661,000Source | 1,354,894,000Source | 933,361,000Source | 922,659,000Source |
| Property, Plant and Equipment, NetUSD | 57,332,000Source | 14,274,000Source | — | — |
| GoodwillUSD | 865,305,000Source | 419,253,000Source | 278,831,000Source | 245,757,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 270,968,000Source | 118,179,000Source | 71,648,000Source | — |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 429,474,000Source | 288,455,000Source | 293,807,000Source | — |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 374,465,000Source | — | — | — |
| Assets, CurrentUSD | 863,313,000Source | 638,496,000Source | 461,507,000Source | 445,423,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 26,264,000Source | 22,861,000Source | 17,450,000Source | — |
| Operating Lease, Right-of-Use AssetUSD | 35,738,000Source | 32,601,000Source | 37,396,000Source | — |
| Other Assets, NoncurrentUSD | 22,528,000Source | 16,021,000Source | 1,877,000Source | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 1,660,327,000Source | 840,726,000Source | 522,593,000Source | 396,967,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 49,000Source | 48,000Source | 47,000Source | — |
| Additional Paid in CapitalUSD | 470,863,000Source | 426,389,000Source | 371,037,000Source | — |
| Retained Earnings (Accumulated Deficit)USD | 308,379,000Source | 286,283,000Source | 243,134,000Source | 151,010,000Source |
| Stockholders' Equity Attributable to ParentUSD | 779,291,000Source | 712,720,000Source | 614,218,000Source | 472,638,000Source |
| Liabilities and EquityUSD | 2,218,661,000Source | 1,354,894,000Source | 933,361,000Source | — |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 615,273,000Source | 365,608,000Source | 218,674,000Source | 155,542,000Source |
| Operating Lease, Liability, CurrentUSD | 7,809,000Source | 5,350,000Source | 4,607,000Source | — |
| Operating Lease, Liability, NoncurrentUSD | 31,552,000Source | 30,654,000Source | 36,289,000Source | — |
| Deferred Income Tax Liabilities, NetUSD | 5,491,000Source | 4,555,000Source | 4,072,000Source | 30,888,000Source |
| Other Liabilities, NoncurrentUSD | 17,107,000Source | 14,003,000Source | 3,586,000Source | — |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 14,005,000Source | 4,006,000Source | 2,433,000Source | — |
| Additional Financial Items | ||||
| Deferred Tax Liabilities, NetUSD | 5,491,000Source | 4,555,000Source | 4,072,000Source | — |
| Dividends Payable, CurrentUSD | — | 638,000Source | 638,000Source | — |
| Dividends PayableUSD | — | — | 0Source | — |
| Long-term Debt, Current MaturitiesUSD | 47,865,000Source | 9,375,000Source | 19,500,000Source | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 990,904,000Source | 425,299,000Source | 258,939,000Source | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 24,076,000Source | 49,932,000Source | 57,849,000Source | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 45,749,000Source | 27,927,000Source | 17,748,000Source | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 38,601,000Source | 34,536,000Source | 22,040,000Source | — |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 9,424,000Source | 44,388,000Source | 26,735,000Source | — |
| Deferred Income Tax Expense (Benefit)USD | -4,287,000Source | -4,250,000Source | -12,444,000Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 114,597,000Source | 52,198,000Source | 68,227,000Source | — |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 548,604,000Source | 146,260,000Source | 6,512,000Source | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -538,999,000Source | -192,395,000Source | -65,523,000Source | — |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | -6,319,000Source | — | — | — |
| Payments to Acquire Property, Plant, and EquipmentUSD | 10,106,000Source | 8,031,000Source | 28,529,000Source | — |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 6,169,000Source | 4,662,000Source | — | — |
| Payments for Repurchase of Common StockUSD | 25,600,000Source | 900,000Source | 10,192,000Source | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 569,346,000Source | 135,146,000Source | 3,421,000Source | — |
| Payments of Ordinary Dividends, Common StockUSD | 7,885,000Source | 4,036,000Source | 62,074,000Source | — |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | 2,307,000Source | — | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 144,944,000Source | -5,051,000Source | 6,125,000Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 434,045,000Source | 289,101,000Source | 294,152,000Source | — |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 45,767,000Source | 30,419,000Source | 14,251,000Source | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 38,600,000Source | 34,536,000Source | 22,040,000Source | — |
| Amortization of Debt Issuance CostsUSD | 4,050,000Source | 1,828,000Source | 1,061,000Source | — |
| Amortization of Intangible AssetsUSD | 40,700,000Source | 25,600,000Source | 12,700,000Source | — |
| Dividends Payable, CurrentUSD | — | 638,000Source | 638,000Source | — |
| Dividends PayableUSD | — | — | 0Source | — |
| Equity Method Investment, Other than Temporary ImpairmentUSD | 0Source | 0Source | — | — |
| Equity Method Investment, Realized Gain (Loss) on DisposalUSD | — | — | 0Source | — |
| Equity Securities, FV-NI, Gain (Loss)USD | — | -135,000Source | 6,629,000Source | — |
| Equity Securities, FV-NI, Realized Gain (Loss)USD | — | -146,000Source | -4,052,000Source | — |
| Equity Securities, FV-NI, Unrealized Gain (Loss)USD | — | 11,000Source | 2,577,000Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | 2,398,000Source | — | — |
| General and Administrative ExpenseUSD | 217,256,000Source | 154,111,000Source | 112,597,000Source | — |
| GoodwillUSD | 865,305,000Source | 419,253,000Source | 278,831,000Source | 245,757,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 0Source | — |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | 0Source | 0Source | — |
| Impairment of Intangible Assets, Finite-livedUSD | 0Source | 0Source | — | — |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | 0Source | 0Source | 0Source | — |
| Income (Loss) from Equity Method InvestmentsUSD | 1,708,000Source | 4,451,000Source | 5,579,000Source | — |
| Income Tax Expense (Benefit)USD | 15,530,000Source | 30,886,000Source | 31,989,000Source | — |
| InterestExpenseNonoperatingUSD | 49,928,000Source | 33,097,000Source | — | — |
| Investment Income, InterestUSD | 12,157,000Source | 14,508,000Source | 14,208,000Source | — |
| Liability for Unpaid Claims and Claims Adjustment Expense, Incurred ClaimsUSD | 1,894,902,000Source | 1,262,428,000Source | 852,935,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | 22,487,000Source | 43,149,000Source | 60,717,000Source | — |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 1,589,000Source | 6,783,000Source | -2,868,000Source | — |
| Nonoperating Income (Expense)USD | -38,919,000Source | -8,532,000Source | 5,225,000Source | — |
| Other Nonoperating Income (Expense)USD | -2,788,000Source | 4,875,000Source | 6,121,000Source | — |
| Proceeds from Issuance of Common StockUSD | — | — | 0Source | — |
| Proceeds from (Payments to) Noncontrolling InterestsUSD | — | 150,000Source | 0Source | — |
| Unrealized Gain (Loss) on DerivativesUSD | — | 0Source | 201,000Source | — |
| Unrealized Gain (Loss) on InvestmentsUSD | -68,000Source | 731,000Source | -4,581,000Source | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 3,181,769,000Source | 2,034,540,000Source | 1,386,661,000Source | 1,144,163,000Source |
| Operating Income (Loss)USD | 78,525,000Source | 89,350,000Source | 84,613,000Source | 104,265,000Source |
| Other Nonoperating Income (Expense)USD | -2,788,000Source | 4,875,000Source | 6,121,000Source | 3,944,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 39,606,000Source | 80,818,000Source | 89,838,000Source | 86,616,000Source |
| Income Tax Expense (Benefit)USD | 15,530,000Source | 30,886,000Source | 31,989,000Source | 40,875,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 1,589,000Source | 6,783,000Source | -2,868,000Source | 570,000Source |
| Net Income (Loss) Attributable to ParentUSD | 22,487,000Source | 43,149,000Source | 60,717,000Source | 45,171,000Source |
| Earnings Per Share, BasicUSD per share | 0.46Source | 0.91Source | 1.3Source | 1Source |
| Earnings Per Share, DilutedUSD per share | 0.46Source | 0.9Source | 1.29Source | 0.99Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 49,075,727Source | 47,597,295Source | 46,553,256Source | 44,971,143Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 49,369,685Source | 47,974,334Source | 46,943,140Source | 45,602,415Source |
| Interest Expense (non-operating)USD | 49,928,000Source | 33,097,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 40,700,000Source | 25,600,000Source | 12,700,000Source | 13,700,000Source |
| Cost of Goods and Service, Excluding Depreciation, Depletion, and AmortizationUSD | 2,840,239,000Source | 1,763,152,000Source | 1,171,703,000Source | 944,685,000Source |
| Cost, Depreciation and AmortizationUSD | 45,749,000Source | 27,927,000Source | 17,748,000Source | 17,543,000Source |
| Costs and ExpensesUSD | 3,103,244,000Source | 1,945,190,000Source | 1,302,048,000Source | 1,039,898,000Source |
| Current Income Tax Expense (Benefit)USD | 19,817,000Source | 35,136,000Source | 44,433,000Source | 55,153,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 5,000,000Source | 2,300,000Source | 5,100,000Source | 3,700,000Source |
| Equity Securities, FV-NI, Realized Gain (Loss)USD | — | -146,000Source | -4,052,000Source | 2,272,000Source |
| General and Administrative ExpenseUSD | 217,256,000Source | 154,111,000Source | 112,597,000Source | 77,670,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 0Source | 0Source |
| Income (Loss) from Equity Method InvestmentsUSD | 1,708,000Source | 4,451,000Source | 5,579,000Source | 5,622,000Source |
| Interest ExpenseUSD | — | — | 16,102,000Source | 7,920,000Source |
| Investment Income, InterestUSD | 12,157,000Source | 14,508,000Source | 14,208,000Source | 1,976,000Source |
| Liability for Unpaid Claims and Claims Adjustment Expense, Incurred ClaimsUSD | 1,894,902,000Source | 1,262,428,000Source | 852,935,000Source | 651,831,000Source |
| Nonoperating Income (Expense)USD | -38,919,000Source | -8,532,000Source | 5,225,000Source | -17,649,000Source |
Filing attachments
tm2625986d1_ex99-1.htm · 8-K · 2026-09-23
Exhibit 99.1 September 2026 BS1 2 Forward Looking Statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward - looking statements include any statements about the Company's business, financial condition, operating results, plans, objectives, expectations and intentions, expansion plans, estimates of our total addressable market, our …
Read attachment ↗tm2625392d1_ex99-1.htm · 8-K · 2026-09-15
EX-99.1 2 tm2625392d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Investor Presentation September 2026 2 Forward Looking Statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward - looking statements include any statements about the Company's business, financial condition, operating results, plans, objectives, expectations and intentio…
Read attachment ↗tm2622348d1_ex99-1.htm · 8-K · 2026-08-06
EX-99.1 2 tm2622348d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Astrana Health, Inc. Reports Second Quarter 2026 Results Company to Host Conference Call on Thursday, August 6, 2026, at 2:30 p.m. PT/5:30 p.m. ET Reports revenue of $972.5 million, up 49% year-over-year, net income of $18.5 million, up 81% year-over-year, and adjusted EBITDA(1) of $68.9 million, up 43% year-over-year for the three months ended June 30, 2026 Reports net cash provided by operating activities of $100.8 mi…
Read attachment ↗tm2622348d1_ex99-2.htm · 8-K · 2026-08-06
EX-99.2 3 tm2622348d1_ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 August 2026 Second Quarter 2026 Earnings Supplement 2 Forward Looking Statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward - looking statements include any statements about the Company's business, financial condition, operating results, plans, objectives, expectatio…
Read attachment ↗tm2620233d1_ex99-1.htm · 8-K · 2026-07-13
EX-99.1 2 tm2620233d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Astrana Health ACOs Deliver $120.4 Million in Gross Shared Savings in 2024 Performance Year All Eight ACOs Achieve Net Shared Savings ALHAMBRA, Calif., July 13, 2026/PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-val…
Read attachment ↗tm2614280d1_ex99-1.htm · 8-K · 2026-05-12
EX-99.1 2 tm2614280d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 M e d i c a r e M e d i c a i d C o m m e r c i al O th e r T h i r d P a r t i es F u l l - r i s k P art i a l - r i sk F u l l - r i s k P art i a l - r i sk C a p i t at i o n, n e t R i s k P o o l S et t l e m e n t s & I n c e nt i v e s M a n a g e m e n t F e e I n c o me F e e - f or - s er v i c e, n e t O th e r In c o me • • • • • Gr o w a d i f f ere n ti a t ed p r o v i d er ne t w o rk B e nd t he c o s t c u r ve…
Read attachment ↗